Institute of Hematology & Blood Diseases Hospital, China: all 402 studies
Page 2 of 5. Open to participants first (296), then studies with results posted, then the rest; newest registration first within each.
- Cohort of Nursing HomesRecruitingNCT07249086
- CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple MyelomaRecruitingNCT07249073Early Phase 1
- SL4903 CAR-T Therapy for Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT07234721Early Phase 1
- CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological TumorsRecruitingNCT07234110Not applicable
- A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell NeoplasmsNot yet recruitingNCT07234045Phase 1
- Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)RecruitingNCT07234019Phase 2
- Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T TherapyRecruitingNCT07212335Early Phase 1
- A Study of CD19 UCAR-T Cells in Subjects With Autoimmune DiseasesNot yet recruitingNCT07212322Not applicable
- CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07201727Early Phase 1
- A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell NeoplasmsNot yet recruitingNCT07200479Phase 1
- Clinical Observation on the Efficacy of Patient-Donor Derived Probiotics in Improving Intestinal Flora Disorder in Patients With Intestinal Acute Graft-Versus-Host Disease (aGVHD)Not yet recruitingNCT07188909Not applicable
- Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute LeukemiaRecruitingNCT07188740Phase 1
- Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and SafetyRecruitingNCT07185503
- IASO104 for the Treatment of Patients With Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT07185490Early Phase 1
- A Single-arm Single-center Trial of Bridging GPRC5D/CD3 Bispecific Antibody Treatment With BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT07185477Early Phase 1
- Ibrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström MacroglobulinemiaNot yet recruitingNCT07169565Phase 1
- Clinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma PatientsRecruitingNCT07169500Phase 1/2
- Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I StudyRecruitingNCT07169487Phase 1
- Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical TrialRecruitingNCT07165769Phase 2
- SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic MalignanciesRecruitingNCT07153068Phase 1/2
- Newly-diagnosed Pediatric Ph-positive B-ALL ProtocolRecruitingNCT07152041Phase 3
- BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed AmyloidosisRecruitingNCT07151690Phase 2
- A Prospective Single-Arm Observational Study of Maribavir for the Treatment of Post Hematopoietic Stem Cell Transplantation Cytomegalovirus InfectionNot yet recruitingNCT07141095
- Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD（ Breakthrough Invasive Fungal Disease） in Patients With Malignant Hematological DiseasesRecruitingNCT07135778
- Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia PatientsRecruitingNCT07132684Phase 3
- MRD-positive AML Clinical StudyRecruitingNCT07131059Not applicable
- Effect of a Simplified Mindfulness Intervention on Health-related Quality of Life in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Prospective Single-Center Randomized Controlled TrialNot yet recruitingNCT07127562Not applicable
- Autologous Hematopoietic Stem Cell Infusion for Prolonged Cytopenia After CAR-T Cell TherapyRecruitingNCT07127289Phase 2
- The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCTRecruitingNCT07126782Early Phase 1
- Radiation Combined With BCMA/CD3 Bispecific Antibody Therapy for Solitary Bone Plasmacytoma With Mild Bone Marrow InfiltrationRecruitingNCT07115667Phase 2
- BCMA/CD3 BsAb Therapy for POEMS SyndromeRecruitingNCT07115654Phase 2
- uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic MalignanciesRecruitingNCT07109518Phase 1
- Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MMRecruitingNCT07109323Phase 1/2
- CD180 CART for Relapsed or Refractory CD180 Positive Hematologic MalignanciesRecruitingNCT07106749Phase 1
- MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple MyelomaRecruitingNCT07106736Phase 2
- Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCLRecruitingNCT07106723Phase 2
- ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple MyelomaRecruitingNCT07106710Phase 2
- ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Primary Plasma Cell LeukemiaRecruitingNCT07106684Phase 2
- A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple MyelomaRecruitingNCT07106671Phase 2
- Efficacy and Safety of UCBT With TMI -Based Conditioning Regimen for Adults With Refractory/Relapsed Aplastic AnemiaNot yet recruitingNCT07078721Phase 2
- A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin LymphomaNot yet recruitingNCT07068906Phase 1
- Romiplostim N01 for Chemotherapy-induced ThrombocytopeniaRecruitingNCT07063225Phase 2
- Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)RecruitingNCT07063199Phase 2
- A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1Not yet recruitingNCT07034508Phase 2
- National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic LeukemiaRecruitingNCT07019766
- National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic AnemiaRecruitingNCT07019038
- Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic AnemiaRecruitingNCT07010237Phase 2
- Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell LymphomaRecruitingNCT06996132Phase 2
- Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional TrialRecruitingNCT06992128Phase 2
- Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience RegistryRecruitingNCT06992076
- Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous LineageNot yet recruitingNCT06991920Not applicable
- A Study of CT0596 in Plasma Cell LeukemiaRecruitingNCT06988059Early Phase 1
- Clinical Study of rhTPO in Hematopoietic Stem Cell Mobilization for Autologous Transplantation in Acute LeukemiaNot yet recruitingNCT06955858Not applicable
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune DiseasesRecruitingNCT06941129Phase 1
- Reproductive and Mental Health of Patients With Aplastic AnemiaRecruitingNCT06936930
- Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic AnemiaRecruitingNCT06921980
- Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome PatientsRecruitingNCT06918834Phase 2
- Selinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms PatientsNot yet recruitingNCT06900088Phase 2
- Optimal Timing of Hepatitis B Vaccination After TransplantsNot yet recruitingNCT06888479Phase 3
- Newly-diagnosed Low Risk Pediatric B-cell ALL ProtocolRecruitingNCT06882057Phase 2/3
- Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT ModelRecruitingNCT06880419Phase 2
- BCMA CAR-T for Dynamic High-risk Multiple MyelomaRecruitingNCT06880393Phase 2
- The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS PatientsRecruitingNCT06880380Phase 1
- A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT06880354Phase 1
- Newly-diagnosed Pediatric T-cell ALL ProtocolRecruitingNCT06855810Phase 2/3
- Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)RecruitingNCT06838962Phase 2
- A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITPRecruitingNCT06838949Phase 2
- An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune ThrombocytopeniaRecruitingNCT06799611Phase 2
- Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary DiseaseRecruitingNCT06793475Not applicable
- BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple MyelomaRecruitingNCT06793449Phase 2
- The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell TransplantationRecruitingNCT06792682Phase 1
- A Study of the Effect of Laughter Therapy on the Mental Health and Quality of Survival of Hematopoietic Stem Cell Transplant PatientsNot yet recruitingNCT06792630Not applicable
- Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCTRecruitingNCT06783790Phase 2
- A Clinical Study of NAD in the Treatment of Immune ThrombocytopeniaRecruitingNCT06776510Phase 1/2
- A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic AnemiaNot yet recruitingNCT06770504Phase 1
- Reduced-dose Conditioning Regimen Containing TBI in HSCT Treating Elderly Patients With Aplastic AnemiaNot yet recruitingNCT06769568Phase 2
- Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL ProtocolRecruitingNCT06764238Phase 2/3
- Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AMLNot yet recruitingNCT06758726Not applicable
- Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CMLRecruitingNCT06757855Phase 1/2
- BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple MyelomaRecruitingNCT06745687Not applicable
- Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1RecruitingNCT06744504Phase 3
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.RecruitingNCT06733610Phase 1
- JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell LymphomasRecruitingNCT06716658Phase 2
- Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL)Not yet recruitingNCT06712173Phase 1
- Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHDEnrolling by invitationNCT06698211
- Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic AnemiaRecruitingNCT06695741Phase 2
- CD19 CAR-T in the Treatment of Relapsed/Refractory Autoimmune DiseasesRecruitingNCT06680388Early Phase 1
- Blinatumomab as Maintenance Therapy in Patients With High-risk B-lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell TransplantationNot yet recruitingNCT06658938Not applicable
- Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALLNot yet recruitingNCT06658925Phase 2
- A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITPRecruitingNCT06658834Phase 2
- Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Re-treatment for Patients With High-Risk Acute Myeloid LeukemiaNot yet recruitingNCT06643195Not applicable
- Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AMLRecruitingNCT06635681Phase 2
- CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic AnemiaRecruitingNCT06622694Phase 1
- Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic AnemiaRecruitingNCT06613880Phase 2
- Twice-per-weekSelinexor, 2 Days MelphalanNot yet recruitingNCT06613035Phase 3
- Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AMLRecruitingNCT06611839Phase 1/2
- Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.RecruitingNCT06608732Phase 2
- Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic LeukemiaRecruitingNCT06608342Phase 2
- National Longitudinal Cohort of Hematological Diseases (NICHE) - CARTRecruitingNCT06607289
- R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell LymphomaRecruitingNCT06594640Phase 1/2
← Institute of Hematology & Blood Diseases Hospital, China overview and focus areas